Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Penfluridol in chronic schizophrenia

D R Doongaji, A S Sheth, J S Apte

    Acta Psychiatrica Belgica
    |July 1, 1981
    PubMed
    Summary

    This study shows penfluridol, a long-acting oral neuroleptic, significantly improved chronic schizophrenia symptoms in most male patients over six months. Side effects were generally mild and temporary.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparative liver transcriptomics of Kadaknath and Aseel chickens reveals molecular basis of their unique nutritional and metabolic traits.

    British poultry science·2026
    Same author

    Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

    Physical review letters·2026
    Same author

    Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

    Physical review letters·2025
    Same author

    Development and validation of a high-density SNP chip tailored for genomic analysis in Indian backyard chickens.

    British poultry science·2025
    Same author

    First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.

    Physical review letters·2025
    Same author

    Probing Strangeness Hadronization with Event-by-Event Production of Multistrange Hadrons.

    Physical review letters·2025

    Area of Science:

    • Psychiatry and Pharmacology

    Background:

    • Chronic schizophrenia presents ongoing treatment challenges.
    • Long-acting oral neuroleptics offer potential for improved adherence and efficacy.

    Purpose of the Study:

    • To evaluate the efficacy and safety of penfluridol in male chronic schizophrenic patients.
    • To assess the impact of a novel long-acting oral neuroleptic on schizophrenia symptomology.

    Main Methods:

    • A 6-month trial involving 28 male chronic schizophrenic patients.
    • Treatment administered as a single weekly dose of penfluridol (20-120 mg).
    • Symptom variables and side effects were systematically monitored.

    Main Results:

    • Significant improvement observed in 24 out of 28 patients.
    • A notable reduction in scores across 21 of 26 assessed symptom variables.
    • Central side effects were mild and transient in most patients, with one withdrawal.

    Conclusions:

    • Penfluridol demonstrates significant efficacy in treating chronic schizophrenia in male patients.
    • The drug is generally well-tolerated, with a favorable side effect profile.
    • Weekly dosing of penfluridol represents a viable therapeutic option for chronic schizophrenia management.

    Related Experiment Videos